Head-to-head · WeighScore
Found vs WellMedr
By GLP-1 ScorecardUpdated
Score comparison
Found has the higher recorded score — 83.5/100 to 63.2/100.
Found grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Found offers compounded, brand-name and oral GLP-1 routes, but their bills differ: compounded plans include medication and care, while branded medication and labs cost extra.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Found | WellMedr |
|---|---|---|
| WeighScore | 83.5/100 | 63.2/100 |
| Grade | B | C |
| Site position | #8 | #221 |
| Semaglutide | $179 first, then $289 every 28 days on the one-term cash compounded plan (labs extra; confirm selected terms) | Advertised from $49/month; selected upfront total, plan term and renewal amount need confirmation |
| Tirzepatide | $219 first, then $359 every 28 days on the one-term cash compounded plan (labs extra; confirm selected terms) | Advertised from $89/month; selected upfront total, plan term and renewal amount need confirmation |
| Coverage | U.S. service with state, treatment and insurance restrictions; confirm your eligibility | General service page lists all 50 states, DC, Puerto Rico and Guam; exact medication, clinical eligibility and pharmacy fulfillment remain conditional |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Yes | Yes |
Site position #8 · B
Strengths
- Current compounded offers include medication, membership and care, with separate semaglutide and tirzepatide price tables
- Branded injection and oral options are listed, subject to prescription, stock and patient-specific terms
- Insurance-track clinical visits and cash-pay care are distinguished in the public billing documents
- Terms name possible independent medical groups and describe check-ins and messaging
What to consider
- Cash compounded renewal rates differ by molecule and recur every 28 days, not a calendar month
- Longer-term advertised rates and upfront-payment wording do not settle the selected charge or supply
- Labs cost extra; insurance-track cost-sharing can add to the bill and does not reimburse compounded-medication fees
- Refund wording about three days and the first consultation conflicts; rejection of a preferred GLP-1 is not disqualification from all treatment
- The assigned compounder, actual treating practice and individual license status remain unresolved
- A brand or oral menu listing does not establish a specific available prescription, complete price or clinical equivalence
Site position #221 · C
Strengths
- Publishes separate descriptions of 21-day billing and fully prepaid three-, six- and twelve-month plans
- The refund policy provides detailed renewal and unused-prepayment rules, although important provisions conflict with the Terms
- Current documents name possible pharmacy partners, including Logos, Emerald and Center City; the assigned facility still needs confirmation
- The safety page distinguishes compounded preparations from FDA-approved products rather than treating shared ingredients as proof of equivalence
What to consider
- Starting $49 and $89 advertisements do not establish the total due today, renewal amount or usable prescription supply; confirm whether membership and medication are separate charges
- Four-week shipping is not the billing calendar; the separately described 21-day plan can generate more frequent charges
- The refund policy accepts cancellation before a charge is submitted, while the Terms require two days’ notice and allow early renewal processing
- Unused-prepayment allocation in the refund policy conflicts with discretionary partial refunds, medication-plan cancellation windows and a nonrefundable first membership month in the Terms; no legal priority is established
- The ninety-day results-refund promise conflicts with policy language denying a results guarantee; clarify the selected written agreement
- The current directory does not establish an available oral or microdose GLP-1 purchase; the homepage labels microdose Coming soon
- Current documents do not identify the assigned clinical practice, clinician, dispenser or physical compounder; general service coverage does not guarantee every preparation
Featured provider
Found
Found scores 83.5/100 (B). Found offers compounded, brand-name and oral GLP-1 routes, but their bills differ: compounded plans include medication and care, while branded medication and labs cost extra.
Commercial relationships affect this placement. The score comparison above is separate.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.